Professional background
– 2022: Full Professor of Biochemistry, Faculty of Pharmacy
– 2018: Awarded the HDR (Habilitation to Supervise Research)
– 2012: Lecturer, Faculty of Pharmacy
– 2011: Postdoctoral Fellowship, Bordeaux Cardio-Thoracic Research Center
– 2007-2010: Postdoctoral Fellowship, Woolcock Institute of Medical Research, Sydney, Australia
– 2004-2007: PhD in Biology and Health Sciences, University of Bordeaux. Role of bronchial smooth muscle cells in the pathophysiology of asthma.
Funding
Grants as Principal investigator
• 2025-2020: ANR PRC (Co-PI avec Fabien Beaufils). Project ICEBERG. Identification of prediCtive biomarkers and pathophysiological mEchanisms of BR1 and BR2, the two nEw bronchial RemodelinG-based endotypes of severe preschool wheezers. 450 k€
• 2024-2025: Fondation Bordeaux Université : Role of bronchial epithelial energy metabolism in pediatric asthma. 20 k€
• 2022-2025 : ANR PRC (Other associated investigators: ML. Andreola (Bordeaux), Harald Wooldrish (Bordeaux), Marc Landry (Bordeaux) et Laure Emmanuelle ZARAGOSI (Nice)). Projet VIRCHILLED. Comparison of SARS-CoV-2, AdenoVIRus and Rhinovirus infection of the respiratory epithelium in CHILdren vs. the eLDerly. 800 k€
• 2021-2023 : Aquitaine Science Transfert (Patrick Berger, Pauline Esteves et Thomas Trian). New biotherapy for the treatment of severe asthma: development of a drug candidate molecule (humanized antibody fragment), an inhibitor of the fatty acid receptor (LDL-R) of bronchial smooth muscle cells in severe asthma. 400 k€
• 2019-2020 : ANR Flash COVID (ML. Andreola, CNRS UMR5234, Harald Wooldrish CNRS UMR5234, Denis Malvy, CHU de Bordeaux et Thomas Trian): Projet “ANACONDA” Analysis of Covid-19 infection and its inflammatory response in a differentiated human bronchial epithelium model. 192 k€
• 2018-2021: ANR JCJC (Thomas Trian): Role of bronchial Smooth muscle on Asthma Exacerbations (ROSAE). 297 k€
Grants as associated investigator
• 2024-2028: ANR PRCI (France/Germany): PI Markus Weckmann (Université de Lübeck). Projet ARMADA ; childhood Asthma: micRobioMe And Dna-methylations in trAined immunity to reset asthma. 600 k€.
• 2024-2028: Programmes Scientifiques de Grande Ambition Régionale (PSGAR) : PI : L.DELHAES, D.MALVY. Projet : Microbial Exposome and Health Risk: The Importance of One Health Management of Issues Related to Zoonotic Influenza EMERG (1,9M€).
• 2021-2024 : AstraZeneca (Södertälje, Suède). (P.Berger) : . Cell interactions between bronchial epithelial cells and structural cells in both asthma and COPD. 150 k€/an pendant 3 ans.
• 2019-2022 : AstraZeneca (Södertälje, Suède). (PO. Girodet) “BENRAMOD” Project : Effect of Benralizumab on bronchial smooth muscle remodeling in asthma. 159 k€
• 2017-2020 : Fondation pour la Recherche Médicale Equipe FRM (P. Berger) : Role of bronchial smooth muscle in asthma exacerbations: pathophysiology of mitochondrial dysfunction and therapeutic implications. 371 k€